Funding
Researcher : Aintzane Zabaleta Azpiroz
11 funding
2026
2021
2020
2019
-
Amyloidosis antibodies project
€19,384.00
-
Evaluation of the therapeutic efficacy of a compound in MM
€88,358.00
-
MECHANISM OF ACTION ANTI-CD38 IN MM AND AML
€91,200.00
-
Evaluation of TriNKET in BMA samples from MM patients
€96,600.00
-
Fibroblast Activation Factor (FAP) in Amyloidosis and MM
€103,260.00